Biogen Inc.
US ˙ NasdaqGS ˙ US09062X1037

SecurityBIIB / Biogen Inc.
InstitutionQuantbot Technologies LP
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Quantbot Technologies LP closes position in BIIB / Biogen Inc.

On May 13, 2026 - Quantbot Technologies LP filed a 13F-HR form disclosing ownership of 0 shares of Biogen Inc. (US:BIIB) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 2 shares of Biogen Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOGEN COM 09062X103 0 -100.00 0
2026-02-10 2025-12-31 13F BIOGEN COM 09062X103 2 -688 -99.71 0 -100.00 0.0000
2025-11-12 2025-09-30 13F BIOGEN COM 09062X103 690 -907 -56.79 97 -52.00 0.0026
2025-08-13 2025-06-30 13F BIOGEN COM 09062X103 1,597 -12,540 -88.70 201 -89.66 0.0051
2025-05-13 2025-03-31 13F BIOGEN COM 09062X103 14,137 11,665 471.89 1,935 411.64 0.0616
2025-02-11 2024-12-31 13F BIOGEN COM 09062X103 2,472 1,694 217.74 378 152.00 0.0138
2024-11-13 2024-09-30 13F BIOGEN COM 09062X103 778 778 151 0.0059
2024-08-09 2024-06-30 13F BIOGEN COM 09062X103 0 -4,108 -100.00 0 -100.00
2024-05-06 2024-03-31 13F BIOGEN COM 09062X103 4,108 3,445 519.61 886 417.54 0.0499
2024-02-14 2023-12-31 13F BIOGEN COM 09062X103 663 -28 -4.05 172 -3.39 0.0100
2023-11-07 2023-09-30 13F BIOGEN COM 09062X103 691 691 178 0.0119
2023-05-12 2023-03-31 13F BIOGEN COM 09062X103 0 -907 -100.00 0 -100.00
2023-02-13 2022-12-31 13F BIOGEN COM 09062X103 907 -2,323 -71.92 251 -70.88 0.0180
2022-11-07 2022-09-30 13F BIOGEN COM 09062X103 3,230 3,037 1,573.58 862 2,110.26 0.0651
2022-08-09 2022-06-30 13F BIOGEN COM 09062X103 193 -5,044 -96.31 39 -96.46 0.0036
2022-05-16 2022-03-31 13F BIOGEN COM 09062X103 5,237 5,137 5,137.00 1,102 4,691.30 0.0961
2022-02-11 2021-12-31 13F BIOGEN COM 09062X103 100 -4,710 -97.92 23 -98.31 0.0019
2021-11-09 2021-09-30 13F BIOGEN COM 09062X103 4,810 4,810 1,361 0.0995
2021-05-14 2021-03-31 13F BIOGEN COM 09062X103 0 -9,158 -100.00 0 -100.00
2021-02-12 2020-12-31 13F BIOGEN COM 09062X103 9,158 9,158 2,242 0.2330
2020-05-13 2020-03-31 13F BIOGEN COM 09062X103 0 -6,003 -100.00 0 -100.00
2020-02-10 2019-12-31 13F BIOGEN COM 09062X103 6,003 -6,572 -52.26 1,781 -39.15 0.1767
2019-11-12 2019-09-30 13F BIOGEN COM 09062X103 12,575 11,875 1,696.43 2,927 1,695.71 0.2886
2019-08-13 2019-06-30 13F BIOGEN COM 09062X103 700 700 163 0.0163
2019-05-13 2019-03-31 13F BIOGEN COM 09062X103 0 -2,902 -100.00 0 -100.00
2019-02-13 2018-12-31 13F BIOGEN COM 09062X103 2,902 2,902 873 0.0855
2018-11-13 2018-09-30 13F BIOGEN COM 09062X103 0 -5,774 -100.00 0 -100.00
2018-08-13 2018-06-30 13F BIOGEN COM 09062X103 5,774 2,746 90.69 1,675 102.05 0.1140
2018-05-11 2018-03-31 13F BIOGEN COM 09062X103 3,028 2,706 840.37 829 712.75 0.0714
2018-02-12 2017-12-31 13F BIOGEN COM 09062X103 322 -3,587 -91.76 102 -91.66 0.0094
2017-11-07 2017-09-30 13F BIOGEN COM 09062X103 3,909 3,699 1,761.43 1,223 2,083.93 0.1173
2017-08-11 2017-06-30 13F BIOGEN COM 09062X103 210 -7,558 -97.30 56 -97.36 0.0053
2017-05-10 2017-03-31 13F BIOGEN COM 09062X103 7,768 -784 -9.17 2,123 -12.45 0.2226
2017-02-09 2016-12-31 13F BIOGEN COM 09062X103 8,552 8,552 2,425 0.2688
2016-08-02 2016-06-30 13F BIOGEN COM 09062X103 0 -247 -100.00 0 -100.00
2016-04-28 2016-03-31 13F BIOGEN COM 09062X103 247 247 0.00 64 0.0102
2015-10-22 2015-09-30 13F BIOGEN COM 09062X103 0 -1,727 -100.00 0 -100.00
2015-07-27 2015-06-30 13F BIOGEN COM 09062X103 1,727 -3,086 -64.12 697 -65.70 0.1249
2015-04-24 2015-03-31 13F BIOGEN COM 09062X103 4,813 4,813 0.00 2,032 0.5030
2015-01-27 2014-12-31 13F BIOGEN IDEC COM 09062X103 0 -739 -100.00 0 -100.00
2014-10-15 2014-09-30 13F BIOGEN IDEC COM 09062X103 739 -5,198 -87.55 244 -86.96 0.0336
2014-07-08 2014-06-30 13F BIOGEN IDEC COM 09062X103 5,937 5,937 1,871 0.2957
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.